Nicholas Ruggiero, MD
Interventional Cardiology · Philadelphia, PANPI 1669686978
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Abbott at 56.0% of the total.
Across 589 payments — averaging $126.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$42K
- Medtronic$9K
- GE HealthCare$9K
- Edwards Lifesciences$5K
- Ancora Heart, Inc.$2K
- Boston Scientific$1K
- plus $6K from 30 others
Across 5 payments — averaging $3558.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$16K
- Medtronic$1K
- Abbott$66
What the payments were for
- Consulting fees$17,45024%
- Speaking & faculty fees$25,96135%
- Travel & lodging$7,62310%
- Food & beverage$23,21931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 94 | $41,572 |
| Medtronic(2 entities) | 175 | $9,263 |
| GE HealthCare | 17 | $9,148 |
| Edwards Lifesciences | 60 | $5,184 |
| Ancora Heart, Inc. | 6 | $2,000 |
| Boston Scientific | 67 | $1,158 |
| Abiomed | 20 | $1,123 |
| Novartis | 56 | $594 |
| Artivion, Inc. | 1 | $436 |
| Asahi Intecc USA, Inc. | 2 | $372 |
| Siemens Medical Solutions USA, Inc. | 4 | $365 |
| Amgen | 15 | $349 |
| Cardiovascular Systems Inc. | 8 | $300 |
| Philips North America LLC | 14 | $287 |
| Galt Medical | 1 | $261 |
| E.r. Squibb & Sons, L.L.C. | 10 | $193 |
| Canon Medical Systems USA, Inc. | 1 | $192 |
| Heartflow, Inc. | 2 | $176 |
| Cook Medical LLC | 2 | $134 |
| W. L. Gore & Associates, Inc. | 1 | $125 |
| Johnson & Johnson | 6 | $122 |
| AstraZeneca | 3 | $110 |
| Inari Medical, Inc. | 3 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| Shockwave Medical, Inc | 5 | $98 |
| Alnylam Pharmaceuticals Inc. | 1 | $89 |
| Atricure, Inc. | 1 | $79 |
| Biotronik Inc. | 3 | $52 |
| Teleflex LLC | 2 | $50 |
| Angiodynamics, Inc. | 1 | $46 |
| Endotronix, Inc. | 1 | $42 |
| Biosense Webster, Inc. | 1 | $30 |
| Recor Medical Inc | 1 | $28 |
| Bard Peripheral Vascular, Inc. | 2 | $27 |
| Livanova USA, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER Occluders$24,739
- AMPLATZER TALISMAN$11,550
- SYMPLICITY G3$3,103
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,178
- TRICLIP$1,176
- TENDYNE$1,074
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,033
- SAPIEN 3 Ultra RESILIA$716
- COREVALVE EVOLUT R$673
- ONYX FRONTIER$473
- Impella$437
- ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$436
- NAVITOR$420
- CoreValve Evolut$407
- RESOLUTE ONYX$315
- AccuCinch$286
- NAEOTOM Alpha$285
- MitraClip$231
- Asahi Peripheral Vascular Wires$219
- PASCAL$214
How this compares
$74,253 in reported general payments places this provider in the 85th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $90,215 |
| XareltoRivaroxaban | 11 | $17,597 |
| Rosuvastatin Calcium | 99 | $2,397 |
| Atorvastatin Calcium | 139 | $1,942 |
| Ranolazine ErRanolazine | 31 | $1,390 |
| Ezetimibe | 34 | $1,071 |
| Metoprolol Succinate | 59 | $1,015 |
| ClopidogrelClopidogrel Bisulfate | 51 | $849 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 34 | $676 |
| Losartan Potassium | 55 | $668 |
| Amlodipine Besylate | 54 | $615 |
| Carvedilol | 44 | $580 |
| Warfarin Sodium | 46 | $450 |
| Furosemide | 77 | $310 |
| Valsartan | 12 | $304 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $122 | $17,59711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 281 interventional cardiology providers in Pennsylvania.
Other interventional cardiology in Philadelphia
- Jon GeorgePhiladelphia$637K
- Sanjog KalraPhiladelphia$444K
- Taisei KobayashiPhiladelphia$384K
- Howard HerrmannPhiladelphia$259K
- Jay GiriPhiladelphia$157K
- Paul FiorilliPhiladelphia$104K
- Craig FrankilPhiladelphia$59K
- Michael BodePhiladelphia$58K
- Oleg VishnevskyPhiladelphia$49K
- Ashwin NathanPhiladelphia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.